BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26770559)

  • 1. Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.
    Li J; Mercer E; Gou X; Lu YJ
    Am J Cancer Res; 2013; 3(2):127-51. PubMed ID: 23593537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancer.
    Rehman K; Iqbal Z; Zhiqin D; Ayub H; Saba N; Khan MA; Yujie L; Duan L
    Cancer Cell Int; 2023 Oct; 23(1):247. PubMed ID: 37858151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol Intake and Alcohol-SNP Interactions Associated with Prostate Cancer Aggressiveness.
    Lin HY; Wang X; Tseng TS; Kao YH; Fang Z; Molina PE; Cheng CH; Berglund AE; Eeles RA; Muir KR; Pashayan N; Haiman CA; Brenner H; Consortium TP; Park JY
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33540941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Cytochrome P450 (CYP) Gene Single-Nucleotide Polymorphisms and Second-to-Fourth Digit Ratio in Chinese University Students.
    Zhang J; Yang M; Luan P; Jia W; Liu Q; Ma Z; Dang J; Lu H; Ma Q; Wang Y; Mu C; Huo Z
    Med Sci Monit; 2021 Mar; 27():e930591. PubMed ID: 33723203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness.
    Robles-Fernandez I; Martinez-Gonzalez LJ; Pascual-Geler M; Cozar JM; Puche-Sanz I; Serrano MJ; Lorente JA; Alvarez-Cubero MJ
    PLoS One; 2017; 12(10):e0185447. PubMed ID: 28981526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in prostate hyperplasia and carcinogenesis.
    Udensi UK; Tchounwou PB
    J Exp Clin Cancer Res; 2016 Sep; 35(1):139. PubMed ID: 27609145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.
    Reichardt JK
    Front Biosci; 1999 Jul; 4():D596-600. PubMed ID: 10417059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact of combined inhibition of 3α-oxidoreductases and 5α-reductases on prostate cancer.
    Fiandalo MV; Gewirth DT; Mohler JL
    Asian J Urol; 2019 Jan; 6(1):50-56. PubMed ID: 30775248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups.
    Poniah P; Mohamed Z; Apalasamy YD; Mohd Zain S; Kuppusamy S; Razack AH
    Int J Clin Exp Med; 2015; 8(10):19232-40. PubMed ID: 26770559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
    Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Urol Oncol; 2015 Jul; 33(7):331.e1-7. PubMed ID: 25960412
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.